C16 Biosciences Revenue and Competitors

Location

$24M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • C16 Biosciences's estimated annual revenue is currently $3.6M per year.(i)
  • C16 Biosciences's estimated revenue per employee is $77,500
  • C16 Biosciences's total funding is $24M.

Employee Data

  • C16 Biosciences has 46 Employees.(i)
  • C16 Biosciences grew their employee count by -6% last year.

C16 Biosciences's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Co-Founder | Head OperationsReveal Email/Phone
3
Chief StaffReveal Email/Phone
4
Head R&DReveal Email/Phone
5
Head Finance and AccountingReveal Email/Phone
6
Senior Director, Downstream ProcessReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Director SustainabilityReveal Email/Phone
9
Director FermentationReveal Email/Phone
10
Pilot Plant ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is C16 Biosciences?

C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.

keywords:N/A

$24M

Total Funding

46

Number of Employees

$3.6M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

C16 Biosciences News

2022-04-17 - No, Green Beauty Is Not Synonymous With All-Natural — Here's Why

Davis references a company called C16 Biosciences, which brews a sustainable alternative to palm oil using its microbes.

2020-03-03 - Palm oil alternative startup C16 Biosciences raises $20 million

C16 Biosciences, a company seeking to commercialize a manufactured alternative to palm oil, announced yesterday that it has raised $20 million in Series A funding…

2020-03-03 - Daily funding roundup - March 3rd, 2020

Tricog raised $10.5M; Talespin landed raised $15M; C16 Biosciences closed $22M [Editor's note: Future of Behavioral and Mental Health with BetterHelp, Headspace, Ginger.io, Providence Hospitals, UnitedHealthcare Optum, Khosla Ventures, Oak HC/FT and more has become 3 virtual conferences and one ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.2M4615%N/A
#2
$8.4M46-39%N/A
#3
$8.9M46-30%N/A
#4
$35M4635%N/A
#5
$8.4M46-34%N/A